Wildcatters welcome
TolerRX's TRX4 enters Phase I dose-escalation trials for the treatment of psoriasis
Initial results of the VALUE trial announced
Priority Paper Alerts
Cancer stem cells discovered in chronic myeloid leukemia
Lipitor® approved for use in the prevention of cardiovascular disease
Pfizer to commit $1.5 milion to US glaucoma eyecare program
SIRT1 longevity protein found to delay the degeneration of nerve cell branches in yeast and worms
FDA approves Eli Lilly's adult antidepressant
Possible link suggested between the use of oral teeth whiteners and the development of oral cavity squamous cell carcinoma
Vitamin D receptor gene alterations increase breast and pancreatic cancer risk
Researchers at Emory University successfully map the structure of the epothilone and taxane drug classes
Etanercept - review of efficacy and safety after five years of clinical use
Omalizumab in the treatment of allergy and asthma
An update on bimatoprost (Lumigan®) in glaucoma therapy
ALLHAT and its implications in the diabetic population
Ximelagatran for stroke prevention in atrial fibrillation
Phase II study of salvage therapy with high-dose tamoxifen and oral etoposide for recurrent malignant glioma
CRM197 and cancer
Erlotinib (Tarceva®) inhibits oral cavity carcinoma and synergizes with cisplatin and ionizing radiation in vitro
Clinical effectiveness of levofloxacin for inflammatory acne with high lesion concentrations
Effects of sliding scale insulin use on glycemic control and length of stay in hospitalized patients with Type 2 diabetes mellitus
Venlafaxine has modest effects in autistic children
Primary systemic therapy in patients with breast cancer
Chemotherapy in brain metastases of lung and breast cancer
New antiarrhythmic agents for atrial fibrillation
Recombinant human activated protein C in sepsis
Early onset schizophrenia
Pharmacotherapy of constipation in children
Treatment of nail disorders